Ajinomoto

What Ajinomoto does

Ajinomoto Co., Inc. is a Japanese food and amino acid science company headquartered in Tokyo, founded in 1909 when Dr. Kikunae Ikeda commercialized umami through AJI-NO-MOTO. The company operates across five core business segments: consumer seasonings and ingredients (AJI-NO-MOTO, HONDASHI, RosDee, Masako, Cook Do, Sajiku), North American frozen foods (Ling Ling, Tai Pei, José Olé — $1.3 billion in 2024 U.S./Canadian sales), semiconductor materials (Ajinomoto Build-up Film, or ABF), pharmaceutical CDMO services, and specialty ingredients including AJIDEW cosmetics moisturizers, AjiPro-L livestock feed supplements, and Pal Sweet low-calorie sweetener. Its products reach consumers in more than 130 countries, while its ABF insulating film — controlling over 95% of global market share — is used by major AI chip designers including Nvidia, Intel, and AMD.

The company's foundation is proprietary amino acid fermentation technology, organized under the "AminoScience" platform and refined over more than 100 years. Core technical assets include ABF for FC-BGA substrate insulation in advanced chip packaging, the AJICAP site-specific antibody-drug conjugate conjugation platform, the Deliciousness Technology / AJI-PMap quantitative sensory analysis system, the Bio-cycle closed-loop fermentation system achieving near-100% co-product conversion, and Palatability Design Technology for sodium and fat reduction. In biopharma, the company operates a CDMO business (viral vectors, plasmid gene therapies, ADC development) anchored by the $620 million acquisition of Forge Biologics in December 2023, and launched the CELLiST AAV Production Supplement in February 2026 to improve gene therapy manufacturing productivity by 1.3 to 2 times.

Ajinomoto generates revenue through a diversified model combining consumer retail (frozen foods and seasonings), direct enterprise sales (ABF to semiconductor manufacturers and substrate makers, with long-term contracts and prepayment arrangements from hyperscalers), B2B food ingredients (Salt Answer sodium reduction platform, umami seasonings for food manufacturers), and pharmaceutical CDMO services. The company reported $10.05 billion in revenue and $463.80 million in net income. The functional materials segment posted 35% operating profit growth with margins exceeding 50% in the fiscal year ended March 2026, and the company announced a 30% ABF price increase effective Q3 2026, reflecting supply-demand imbalance in AI semiconductor packaging. The business has been actively reshaped through M&A, including the acquisition of Windsor Quality Holdings (2014, frozen foods) and Forge Biologics (2023, gene therapy CDMO), the divestiture of Ajinomoto Althea to PCI Pharma Services (May 2025), the proposed privatization of Ajinomoto (Malaysia) Berhad (June 2026), and the acquisition of a 50.1% stake in More Than Gourmet Holdings (April 2026).

Name

Ajinomoto

Legal name

Ajinomoto Co., Inc.

Website

https://ajinomoto.com

Company type

Public

Founded year

1909

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Ajinomoto Co., Inc. is a Japanese amino acid science company that produces seasonings (AJI-NO-MOTO), frozen foods (Ling Ling, Tai Pei), semiconductor packaging materials (ABF, 95%+ global share), and pharmaceutical CDMO services, serving consumers in 130+ countries and AI chip designers including Nvidia, Intel, and AMD.

Ownership category

akta.pro rank

Product category

Food Seasonings and Amino Acid Products

NAICS

Food Manufacturing (311), Frozen Specialty Food Manufacturing (311412), Mayonnaise, Dressing, and Other Prepared Sauce Manufacturing (311941)

SIC

Food And Kindred Products (2000), Canned, Frozen & Preservd Fruit, Veg & Food Specialties (2030), Miscellaneous Food Preparations & Kindred Products (2090)

akta.pro primary industry

Frozen Breakfast Foods (CRADADAC)

akta.pro secondary industries

Refrigerated & Frozen Doughs and Batters Manufacturing (AFAKACAM), mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC)

Keywords

• Umami seasonings
• Frozen Asian foods
• Amino acid science
• Semiconductor packaging films
• Biopharmaceutical CDMO services

Headquarters

HQ city

Tokyo

HQ country

Japan

HQ region

Asia

Offices5 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Frozen Foods: Major business segment including brands like Ling Ling, Tai Pei, and José Olé. Reached $1.3 billion in U.S. and Canadian sales in 2024. Products include frozen rice, dumplings, noodles, fried rice, ramen, and desserts. Distribution through retail stores across North America.
2. Functional Materials (ABF): Ajinomoto Build-up Film (ABF) for semiconductor packaging. The company holds over 95% of the global ABF market. The functional materials segment posted 35% operating profit growth with margins exceeding 50% in fiscal year ended March 2026. ABF market projected to grow from $11.56 billion in 2026 to $49.63 billion by 2032.
3. Seasonings and Ingredients: Core business including AJI-NO-MOTO® umami seasoning, MSG, and various flavor seasonings. Products sold in more than 130 countries. Annual production approximately 700,000 tons of umami seasoning.
4. Pharmaceutical CDMO: Contract development and manufacturing services for biopharmaceuticals including viral vectors, plasmid gene therapies, and antibody-drug conjugates. Expanded through acquisition of Forge Biologics for $620 million in December 2023.
5. Plant-Based Meat Technology: Ajinomoto advances plant-based meat technology through amino acid optimization. The company developed a plant-based transferrin as a cost-reduction solution for cultivated meat production.
6. Sodium Reduction Solutions: Salt reduction platforms including Salt Answer for food manufacturers looking to reduce sodium content while maintaining taste. Part of the company's Nutrition Without Compromise initiative.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

Core offering

Ajinomoto Co., Inc. is a diversified Japanese food and biotechnology company that manufactures and sells umami seasonings (AJI-NO-MOTO®, MSG, HONDASHI®, RosDee®, Cook Do®, Masako®), frozen Asian and Mexican foods (Ling Ling, Tai Pei, José Olé), specialty ingredients (AJIDEW™ cosmetics moisturizers, Pal Sweet® sweetener, AjiPro™-L feed supplement), semiconductor packaging materials (Ajinomoto Build-up Film/ABF with over 95% global market share), and biopharmaceutical CDMO services including gene therapy manufacturing (Forge Biologics) and the AJICAP™ ADC platform. The company operates across more than 130 countries.

Product overview

The Ajinomoto Group is a diversified Japanese food and biotechnology company organized around 'AminoScience,' leveraging over 100 years of expertise in amino acid research. The company's product portfolio spans five core segments: (1) Core seasonings including AJI-NO-MOTO® umami seasoning, HONDASHI® dashi, and regional seasonings like RosDee® (Thailand), Cook Do®, Sajiku®, and Masako®; (2) Frozen foods including TAI PEI®, Ling Ling, and José Olé brands acquired via Windsor Quality Holdings in 2014; (3) Specialty ingredients including AJIDEW™ moisturizing agents for cosmetics, Pal Sweet® low-calorie sweetener, and AjiPro™-L livestock feed supplement; (4) Semiconductor materials featuring Ajinomoto Build-up Film (ABF), the dominant insulating film for AI chip packaging; and (5) Biopharmaceutical services including the AJICAP™ ADC platform, Forge Biologics CDMO operations, and CELLIŠT™ gene therapy products. The company operates through a 'Big Kitchen' philosophy, applying proprietary Deliciousness Technology and Palatability Design Technology across its global operations in more than 130 countries.

Differentiator

Problem solved

Functional benefit

Brands

• Ling Ling: Asian-inspired frozen food brand including dumplings, noodles, and fried rice
• Tai Pei
• José Olé
• AJI-NO-MOTO®
• Ajinomoto
• AJIDEW™
• HONDASHI®
• Masako®
• RosDee®

Products and services

• AJI-NO-MOTO® Umami Seasoning The flagship umami seasoning, a pure glutamate-based seasoning providing the savory fifth taste discovered by Dr. Kikunae Ikeda. Sold globally to consumers in more than 130 countries, with annual production of approximately 700,000 tons.
• HONDASHI® Dashi Soup Stock A granulated Japanese soup stock (dashi) made from skipjack tuna (katsuo), providing rich umami flavor essential to Japanese cuisine (washoku). Sold to consumers in Japan and select markets.
• RosDee® Flavor Seasoning A popular flavor seasoning in Thailand introduced in 1979, used in various dishes from soups and stir-fries to direct dipping. Market leader in Thailand's flavor seasoning sector.
• AJIDEW™ Amino Acid Moisturizer A plant-derived, amino acid-based moisturizing ingredient developed in 1971 that mimics the natural moisturizing factors (NMF) in human skin. Used in cosmetics and skincare products worldwide. Includes AJIDEW™ NL-50, AJIDEW™ A-100, and AJIDEW™ ZN-100.
• AjiPro™-L Livestock Feed Supplement A feed supplement for dairy and beef cattle that helps reduce greenhouse gas emissions while boosting milk production. Winner of the FY2023 ASV Awards Gold Award. Sold to livestock producers.
• Ajinomoto Build-up Film (ABF) A critical interlayer insulating film used in advanced semiconductor packaging, particularly FC-BGA substrates for high-performance processors, GPUs, and AI accelerators. Ajinomoto controls over 95% of the global ABF market. Sold to major semiconductor manufacturers including Nvidia, Intel, and AMD.
• AJICAP™ ADC Conjugation Platform A site-specific antibody-drug conjugate (ADC) conjugation platform that enables precise chemical modification at defined lysine residues without antibody engineering. Used for next-generation targeted therapeutics development. Licensed to biopharma partners including Astellas.
• Pal Sweet® Low-Calorie Sweetener A low-calorie sweetener derived from protein-based amino acids, used as a sugar substitute by consumers and commercial food producers.
• Tai Pei® Frozen Entrées A brand of Asian-inspired frozen entrées, part of Ajinomoto's frozen foods portfolio acquired through the 2014 Windsor Quality Holdings acquisition. Offers significant sodium and calorie reduction with improved taste and texture. Sold through retail grocery stores in North America.
• Ling Ling® Frozen Asian Foods A frozen Asian food brand acquired in 2014 as part of the Windsor Quality Holdings acquisition, including dumplings, noodles, fried rice, ramen, and desserts. Serves U.S. and Canadian retail markets.
• José Olé® Mexican-Style Frozen Foods A Mexican-style frozen food brand in Ajinomoto Foods North America's portfolio, sold alongside Ajinomoto, Ling Ling, and Tai Pei brands.
• Cook Do® Menu-Specific Seasonings Menu-specific seasonings tailored to local ingredients, making cooking easier for consumers in countries throughout Asia, South America, and Africa.
• Masako® Flavor Seasoning Ajinomoto Indonesia's flagship flavor seasoning product made of top quality meat and spices, used to make home-cooked meals more delicious with real meaty flavor.
• Sajiku® Indonesian Flour Seasoning Flour seasoning product tailored to local Indonesian ingredients, part of Ajinomoto's localized product range for Asian markets.
• DeliDawa™ Fermented Bean Powder A fermented bean powder used to flavor stews in West Africa, developed as part of Ajinomoto's efforts to provide accessible, nutritious food solutions.
• Forge Biologics CDMO Services A U.S.-based contract development and manufacturing organization (CDMO) acquired by Ajinomoto in December 2023 for $620 million. Specializes in viral vectors and plasmid gene therapies for the gene therapy market, serving biopharmaceutical clients.
• CELLiST™ AAV Production Supplement 1 A new cell culture medium supplement launched in February 2026 designed to enhance viral vector productivity in gene therapy manufacturing. Improves viral vector manufacturing productivity by 1.3 to 2 times compared to conventional methods. Developed by Ajinomoto CELLiST Korea in collaboration with Forge Biologics.
• Salt Answer Sodium Reduction Platform B2B ingredient platform enabling food manufacturers to reduce sodium content while maintaining taste. Part of the company's Nutrition Without Compromise initiative, enabling 22-35% sodium reduction using MSG while maintaining sensory acceptability.
• More Than Gourmet Bone Broths and Stocks Ohio-based producer of culinary-grade bone broths, stocks, and sauces, in which Ajinomoto acquired a 50.1% majority interest in April 2026. Helps scale manufacturing capabilities and expand global reach for bone broth products.

Quantifiable outcome

• 22-35% sodium reduction using MSG while maintaining sensory acceptability
• +5 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Nine partnerships are on record, tiered minor and core.

• Uzbekistan GovernmentminorStrategic or Co-development Partner · 18 June 2026Deputy Minister Ilzat Kasimov of Uzbekistan met with Ajinomoto representatives to explore investment project for establishing MSG production facility in Uzbekistan with plans for Uzbekistan Umami Month event.
• SuperMeatminorStrategic or Co-development Partner · 12 May 2026R&D and technology development agreements with Israeli cultivated meat startup SuperMeat. SuperMeat plans Switzerland launch through partnerships with Ajinomoto and Micarna. Ajinomoto contributes to commercialization through licensing-led model.
• DAIVID & ADIN.AIminorGTM or Marketing Partner · 27 April 2026Ajinomoto is the first client for DAIVID and ADIN.AI's partnership integrating AI-driven creative effectiveness models into enterprise marketing platform.
• The St. JamesminorStrategic or Co-development Partner · 22 April 2026Ajinomoto Foods North America partnership with sports and wellness complex The St. James in Washington D.C. region to integrate well-being into athletic performance through on-site activations.
• Standing OvationminorStrategic or Co-development Partner · 31 March 2026Exclusive partnership with French precision fermentation startup Standing Ovation for manufacturing scale-up of dairy casein proteins. Ajinomoto provides manufacturing expertise for US market launch planned 2026.
• PCI Pharma ServicesminorOthers · 1 May 2025Ajinomoto sold its US-based sterile fill-finish CDMO Ajinomoto Althea to PCI Pharma Services, completing transaction on May 1, 2025.
• Forge BiologicscoreStrategic or Co-development Partner · 1 December 2023Ajinomoto acquired US-based Forge Biologics for $620 million to expand capabilities in viral vectors and plasmid gene therapies for gene therapy CDMO market.
• AstellascoreStrategic or Co-development PartnerAstellas has established agreement with Ajinomoto to access its antibody-drug conjugate development platform AJICAP. Astellas' Chief Manufacturing Officer views reliable supply and bridging research as production 'north star.'
• Intertek AlchemyminorImplementation/ SI/ Consulting PartnerAjinomoto Co., Inc. partnered with Intertek Alchemy to implement training program for employee development, supervisor support, and operational efficiency with cross-training and qualification tracking.

Scale indicators15 records

Recent moves10 records

Expansion highlights6 records

Broad incumbents

• Nestlé: World's largest food and beverage company with a similarly diversified portfolio spanning seasonings, frozen foods, and nutrition. Directly comparable in CPG food scale, global distribution across 130+ markets, and growing focus on health/wellness repositioning.
• Lonza Group: Global CDMO leader in biologics, cell and gene therapy, and small molecules. Comparable to Ajinomoto's Forge Biologics and AJICAP platform in the biopharma services space, with a similar contract manufacturing model and gene therapy exposure.

Direct peers

• Kikkoman: Japanese soy sauce and seasoning manufacturer with a century-old brand (similar to AJI-NO-MOTO®), global distribution, and B2B foodservice channels. Highly comparable in product category, regional strengths in Asia, and seasoning-led business model.
• Kewpie: Japanese mayonnaise, dressing, and processed food company with a similar product mix of sauces, dressings, and processed foods. Comparable in Asian market seasoning category and shared B2B/B2C split across foodservice and retail.
• McCormick & Company: Global leader in spices, seasonings, and flavors with strong B2B ingredient solutions (like Ajinomoto's Salt Answer platform). Directly comparable in flavor science R&D, foodservice and food manufacturing customer base, and a stated focus on health-and-wellness reformulation.
• Conagra Brands: U.S. frozen foods major (Healthy Choice, Marie Callender's, etc.) operating at comparable scale to Ajinomoto Foods North America ($1.3B). Direct peer in retail frozen meals, with overlap in retail grocery distribution and similar margin/cost dynamics in U.S. retail.

Regional players

• Tingyi (Cayman Islands) Holding Corp. Major Chinese instant noodles and frozen foods manufacturer with a similar Asian frozen/noodle product portfolio. Comparable in scale and product category but concentrated in Greater China rather than Ajinomoto's global reach.

Emerging players

• Showa Denko (now Resonac Holdings): Japanese semiconductor materials supplier (CMP slurries, packaging materials) that competes in adjacent semiconductor packaging material categories. Relevant peer for Ajinomoto's ABF business as a fellow Japanese specialty materials supplier to the chip industry.
• Samsung Biologics: Major Asian CDMO with rapidly expanding gene therapy and ADC capabilities. Comparable to Forge Biologics' CDMO positioning and to Ajinomoto's broader move into biopharma manufacturing, with similar hyperscaler-like customer concentration in pharma.

Others

• Mitsui Chemicals (functional materials peer for ABF substrates): Japanese chemical company with semiconductor and specialty materials exposure relevant to ABF value chain. Included as a thematically related materials supplier and potential competitor/customer in advanced packaging substrates.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/ajinomoto-co--inc
• Facebookfacebook.com/ajinomoto-north-america-inc-365681990112942

Revenue estimate

Valuation estimate

Number of profiles

Profiles23 records

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A7 records

Investments18 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ajinomoto